vcfirmsdirectory.com

Venture capital

Foresite Capital

West Hollywood · New YorkRegistered · West Hollywood
New investments · 12 months
Fund vehiclesPublic
9
9 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: foresitecapital.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Foresite Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Foresite Capital right for your round?

Is Foresite Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
9
9 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

FORESITE CAPITAL FUND VI LPUS private fund · Active · United States · $1.1B gross assets · filed 30 Jul 2026
FORESITE CAPITAL FUND IV, LPUS private fund · Active · United States · $860M gross assets · filed 30 Jul 2026
FORESITE CAPITAL FUND V, L.P.US private fund · Active · United States · $753.9M gross assets · filed 30 Jul 2026
FORESITE CAPITAL OPPORTUNITY FUND V, L.P.US private fund · Active · United States · $227.4M gross assets · filed 30 Jul 2026
FORESITE LABS FUND I, L.P.US private fund · Active · United States · $130.8M gross assets · filed 30 Jul 2026
FORESITE CAPITAL FUND III, LPUS private fund · Active · United States · $110.7M gross assets · filed 30 Jul 2026
FORESITE CAPITAL VI-A, LLCUS private fund · Active · United States · $18M gross assets · filed 30 Jul 2026
FORESITE CAPITAL FUND II, LPUS private fund · Active · United States · $10.8M gross assets · filed 30 Jul 2026
FORESITE PUBLIC & CROSSOVER OPPORTUNITIES FUND I, L.P.US private fund · Active · United States · $0 gross assets · filed 30 Jul 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Foresite Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

3 rounds in the last 12 months

Round sizes, Foresite Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

10x Genomics89 Bio, Inc.Abdera TherapeuticsAcceleron PharmaAclaris Therapeutics, Inc.Adaptimmune Therapeutics PLCAdaptive Biotechnologies CorporationAdicet Bio, Inc.Aduro BiotechAerie Pharmaceuticals, Inc.and 173 more

Portfolio and exits

Every company Foresite Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Foresite Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Foresite Capital

Events where Foresite Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Foresite Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

6 Oct 2026New deal
30 Jul 2026Fund filingForm ADV filed by FORESITE CAPITAL: 9 private funds, $3.2B in gross assets.SEC Form ADV · public record
9 Jun 2026New deal
3 Feb 2026New deal
18 Sep 2025New deal
25 Apr 2024New deal

Founders also look at

Frequently asked questions

Foresite Capital is based in West Hollywood, United States. It also has an office in New York.

9 fund vehicles are on public registers (SEC adviser filings), including FORESITE CAPITAL FUND VI LP, FORESITE CAPITAL FUND IV, LP and FORESITE CAPITAL FUND V, L.P.

Sectors: Biotech, Life sciences. From the firm’s own website.

Backs businesses that combine technology and biotech, using biology and big data to personalize healthcare and speed up product development. The firm invests at every stage, works closely with portfolio companies through scientists and data scientists, and draws on its operating experience and networks. From the firm’s own website.

Foresite Capital lists 183 portfolio companies on its website, including 10x Genomics, 89 Bio, Inc., Abdera Therapeutics, Acceleron Pharma and Aclaris Therapeutics, Inc..

Firms whose websites list some of the same companies include RA Capital, Aisling Capital and ARCH Venture Partners.

Know before Foresite Capital’s next round is announced.

PRO tracks Foresite Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Foresite CapitalGet Foresite Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.